marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 09-06-2024
Anixa Biosciences Financial Ratios 2011-2024 | ANIX
Annual Financial Ratios Anixa Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -4.6 | -5.8 | -6.5 | -4.9 | -6.1 | -10.9 | -19.6 | -4.2 | -4.5 | -9.4 | -3.2 |
P/S |
0.7 | - | 117.4 | - | 303.2 | 62.1 | 84.1 | 182.4 | 2.9 | 11.1 | 116.7 | 42.2 | 23.8 |
EPS |
0.3 | 0.5 | -0.5 | -0.5 | -0.6 | -0.8 | -0.6 | -0.6 | -16 | -1.1 | -0.1 | -0.0 | -0.0 |
EV (Enterprise Value) |
1.39 M | -10 M | 32.5 M | 53 M | 73.8 M | 67.3 M | 28 M | 56.9 M | 27 M | 42.4 M | 53.2 M | 46.4 M | 30.6 M |
EBITDA per Share |
-355 | -457 | -0.44 | -0.447 | -0.558 | -0.759 | -0.471 | -0.436 | -0.0644 | -0.494 | -0.916 | -0.517 | -0.685 |
EV/EBITDA |
-2.2 | -5.3 | -6.5 | -4.9 | -4.7 | -12.5 | -36.6 | -7.9 | -6.3 | -9.6 | -4.6 | ||
PEG |
-0.0 | -0.0 | -1.09 | -0.25 | -0.26 | 0.14 | 0.52 | 0.04 | -0.23 | -0.21 | 0.03 | -0.19 | 0.1 |
P/B |
0.0 | 0.0 | 1.7 | 7.1 | 15.7 | 13.3 | 3.8 | 55.4 | 5.4 | 10.1 | -13.7 | -33.4 | 22.5 |
P/CF |
-0.0 | -0.0 | -12.2 | 2435.1 | -15.4 | -16.0 | -8.0 | -15.5 | 20.7 | -17.1 | -14.2 | -12.7 | -32.9 |
ROE % |
-40.31 | -46.80 | -36.55 | -122.12 | -242.02 | -270.01 | -63.22 | -508.01 | -27.29 | -239.58 | 303.56 | 356.16 | -697.34 |
ROA % |
-38.44 | -44.70 | -35.73 | -106.76 | -185.06 | -217.04 | -56.84 | -89.13 | -14.77 | -106.08 | -185.31 | -75.13 | -85.34 |
ROCE % |
-45.24 | -47.77 | -37.07 | -120.74 | -238.37 | -264.42 | -76.68 | -87.39 | -10.81 | -69.61 | -355.37 | -107.72 | -76.88 |
Current Ratio |
11.9 | 13.7 | 24.3 | 7.9 | 4.1 | 4.4 | 7.9 | 7.3 | 11.6 | 3.5 | 0.4 | 0.5 | 1.5 |
DSO |
274.6 | - | - | - | 97.1 | - | - | - | - | 39.8 | 164.3 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 1286.2 | 276.5 | 1676.8 | 787.0 | 37.5 | 99.2 | 607.7 | 28698.9 | 4012.9 |
Operating Cycle |
274.6 | - | - | - | 97.1 | - | - | - | - | 39.8 | 164.3 | - | - |
Cash Conversion Cycle |
274.6 | - | - | - | -1189.0 | -276.5 | -1676.8 | -787.0 | -37.5 | -59.4 | -443.4 | -28698.9 | -4012.9 |
All numbers in USD currency
Quarterly Financial Ratios Anixa Biosciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1 | -0.1 | 0.1 | - | -0.08 | -0.07 | 0.08 | -0.33 | -0.09 | -0.12 | -0.09 | -0.32 | -0.14 | -0.08 | -0.13 | -0.36 | -0.11 | -0.12 | -0.25 | -0.49 | -0.11 | -0.13 | -0.11 | -0.5 | -0.3 | -0.08 | -0.41 | -0.47 | -0.12 | 0.02 | -0.18 | -0.45 | -0.13 | -0.15 | 0.43 | -0.01 | -0.18 | -0.26 | -0.02 | -0.75 | 0.05 | -0.02 | -0.01 | -0.04 | -0.01 | -0.01 | - | -0.01 | - | - | -0.01 | -0.02 | -0.01 | -0.01 |
EBITDA per Share |
- | - | - | - | - | - | -82.7 | -0.33 | -91.8 | -0.12 | -0.09 | -0.3 | -0.14 | -0.09 | -0.13 | -0.36 | -0.1 | -0.13 | -0.26 | -0.5 | -0.11 | -0.13 | -0.11 | -0.51 | -0.3 | -0.08 | -0.16 | -0.39 | -0.12 | -0.12 | -0.17 | -0.41 | -0.11 | -0.12 | 0.44 | 0.05 | -0.16 | -0.23 | -0.01 | -0.38 | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | - | -0.01 | - | - | - | -0.02 | -0.01 | -0.01 |
ROE % |
-51.78 | -46.94 | -42.49 | -27.67 | -62.51 | -61.18 | -63.63 | -71.24 | -61.63 | -64.84 | -60.32 | -91.70 | -155.44 | -172.59 | -195.95 | -238.98 | -332.61 | -344.25 | -363.30 | -301.22 | -281.49 | -341.39 | -317.57 | -194.78 | -72.60 | 5.53 | 32.92 | -105.67 | -466.89 | -556.02 | -686.85 | -597.05 | -196.85 | -116.78 | -32.24 | -13.92 | -173.15 | -131.19 | -167.98 | -73.50 | 302.86 | 370.37 | 525.99 | 247.68 | 188.07 | 163.01 | 161.88 | 18.13 | -401.51 | -621.82 | -553.09 | -263.83 | -167.62 | -121.64 |
ROA % |
-49.47 | -44.61 | -40.01 | -24.33 | -57.60 | -56.59 | -59.10 | -67.63 | -59.02 | -62.28 | -58.09 | -70.40 | -128.19 | -143.60 | -164.91 | -214.24 | -283.68 | -290.58 | -303.57 | -251.35 | -236.72 | -287.65 | -268.11 | -328.87 | -228.18 | -163.61 | -140.41 | -73.54 | -107.48 | -106.73 | -131.15 | -84.45 | -14.86 | -12.41 | -13.77 | -77.05 | -147.38 | -125.68 | -137.60 | -130.46 | -190.70 | -242.71 | -252.35 | -235.53 | -136.89 | -100.54 | -70.51 | -91.76 | -91.18 | -100.58 | -67.68 | -32.29 | -20.51 | -14.89 |
ROCE % |
-57.41 | -52.48 | -47.68 | -30.94 | -66.29 | -63.77 | -65.32 | -72.24 | -62.46 | -65.65 | -61.10 | -92.98 | -155.71 | -171.28 | -194.88 | -237.53 | -335.68 | -349.61 | -368.66 | -306.84 | -283.80 | -345.22 | -321.47 | -255.81 | -147.14 | -65.84 | -55.37 | -132.90 | -442.28 | -519.16 | -620.15 | -532.45 | -163.71 | -94.48 | -20.40 | -32.45 | -123.84 | -98.32 | -89.91 | 31.99 | 303.75 | 374.55 | 464.09 | 187.31 | 204.06 | 191.12 | 208.93 | -50.92 | -632.73 | -800.75 | -615.91 | -380.08 | -114.14 | -121.69 |
Current Ratio |
10.3 | 13.7 | 14.3 | 11.9 | 13.3 | 16.4 | 17.6 | 13.8 | 19.7 | 23.6 | - | 24.3 | - | 24.3 | 8.1 | 8.0 | 7.7 | 8.6 | - | 4.2 | 4.2 | 4.2 | - | - | - | - | 0.5 | 9.9 | 3.0 | 2.4 | 1.7 | 1.2 | 1.2 | 1.2 | 2.6 | 2.2 | 2.2 | 2.2 | - | 1.8 | 1.8 | 1.8 | - | 0.6 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 55.6 | 4.2 | - | - | - | - | - | - | - | - | - | - | - | - | 24.3 | 24.3 | 12.1 | - | 25.2 | 38.6 | - | - | 27.8 | 27.8 | - | - | - | - | - | 0.2 | - | - | - | - | 15.9 | 30.7 | 16.5 | 3748.5 | - | - | - | 0.7 | 912.5 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.5 | 1.4 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 46.7 | - | - | 12.1 | 31.2 | - |
Operating Cycle |
- | - | - | - | - | 55.6 | 4.2 | - | - | - | - | - | - | - | - | - | - | - | - | 24.3 | 24.3 | 12.1 | - | 25.2 | 38.6 | - | - | 27.8 | 27.8 | - | - | - | - | - | 0.2 | - | - | - | - | 15.9 | 30.7 | 16.5 | 3748.5 | - | - | - | 0.7 | 912.5 | - | - | - | 0.5 | 1.4 | - |
Cash Conversion Cycle |
- | - | - | - | - | 55.6 | 4.2 | - | - | - | - | - | - | - | - | - | - | - | - | 24.3 | 24.3 | 12.1 | - | 25.2 | 38.6 | - | - | 27.8 | 27.8 | - | - | - | - | - | 0.2 | - | - | - | - | 15.9 | 30.7 | 16.5 | 3748.5 | - | - | - | 0.7 | 912.5 | -46.7 | - | - | -11.5 | -29.9 | - |
All numbers in USD currency